Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vas Narasimhan
Fierce Pharma
Novartis CEO Vas Narasimhan joins Anthropic's board
Vas Narasimhan's appointment also comes as Anthropic is embroiled in a high-profile legal dispute with the Pentagon over the use of its AI models.
Angus Liu
Apr 15, 2026 10:36am
Fierce Pharma
Novartis pledges nearly $480M to bolster China production, R&D
Mar 23, 2026 10:35am
Why Novartis CEO was willing to pay top dollar for Avidity
Nov 20, 2025 4:37am
Will Novartis catch the PD-1 bispecific wave? CEO weighs in
Jan 31, 2025 3:30am
Novartis 'took data to heart' before slimming pipeline by 40%
Nov 21, 2024 5:07am
Novartis' cholesterol buster, new trials fall victim to COVID-19
Apr 28, 2020 10:40am
